The search of new predictor markers for disease outcomes and treatment efficacy is crucial for metastatic sarcoma, where prognosis is unfavourable and the choice of chemotherapy is limited. In our work we present the results of in vitro clonogenic abilities study of tumor cells connection with immunological parameters of peripheral blood and survival rate of patients with metastatic soft tissue sarcomas and bones sarcomas (STBS).